Literature DB >> 7336575

The distribution of metastases in the liver. A quantitative postmortem study.

W Schulz, W Hort.   

Abstract

Seventy-five livers with metastases were cut sagitally into 1 cm thick slices. A total number of 11,581 metastases sections was exactly mapped. There was an average of 154 metastases sections per liver. The average diameter of the metastases was 1 cm. 40% of the metastases reached to the hepatic surface, and 60% were invisible due to their deposition in the internal parenchyma. In 8% of the livers there were only superficial metastases (average 3.2 metastases), and in 12% were only deep metastases detected (average 2.6). The total number of superficial metastases increased with increasing diameter of the secondary tumors. An approximately homogeneous distribution of hepatic metastases within the liver parenchyma has been demonstrated.

Entities:  

Mesh:

Year:  1981        PMID: 7336575     DOI: 10.1007/bf00431667

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  12 in total

1.  Hepatic lobectomy for metastatic cancer.

Authors:  A BRUNSCHWIG
Journal:  Cancer       Date:  1963-03       Impact factor: 6.860

2.  Metastatic cancer of the liver; the clinical problem and its management.

Authors:  G T PACK; R D BRASFIELD
Journal:  Am J Surg       Date:  1955-11       Impact factor: 2.565

Review 3.  [Partial hepatectomy in liver metastasis].

Authors:  F Wanger
Journal:  Helv Chir Acta       Date:  1974-12

Review 4.  Survival after liver resection for cancer.

Authors:  J H Foster
Journal:  Cancer       Date:  1970-09       Impact factor: 6.860

5.  [Resection of metastases and recurrences (author's transl)].

Authors:  G Hegemann; E Mühe
Journal:  Dtsch Med Wochenschr       Date:  1974-05-10       Impact factor: 0.628

6.  Carcinoma of the colon with liver metastases. Operative indications and prognosis.

Authors:  J Nielsen; I Balslev; H E Jensen
Journal:  Acta Chir Scand       Date:  1971

7.  The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy.

Authors:  S Bengmark; L Hafström
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

8.  [The problems of early diagnosis of liver metastases: an evaluation of the individual diagnostic procedures (author's transl)].

Authors:  H Sabitzer; E Deimer; G Hohenberg; J Wickenhauser
Journal:  Wien Klin Wochenschr       Date:  1974-10-18       Impact factor: 1.704

9.  Hepatic resection for metastatic cancer.

Authors:  L Flanagan; J H Foster
Journal:  Am J Surg       Date:  1967-04       Impact factor: 2.565

10.  Invasion of the hepatic capsule by tumour metastases to the liver.

Authors:  R L Josephson; A C Wallace
Journal:  Pathology       Date:  1978-04       Impact factor: 5.306

View more
  5 in total

1.  Value of visual inspection, bimanual palpation, and intraoperative ultrasonography during hepatic resection for liver metastases of colorectal carcinoma.

Authors:  Shojiro Hata; Hiroshi Imamura; Taku Aoki; Takuya Hashimoto; Masaaki Akahane; Kiyoshi Hasegawa; Yoshifumi Bekku; Yasuhiko Sugawara; Masatoshi Makuuchi; Norihiro Kokudo
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

2.  Characterization of the frequency distribution for human hematogenous metastases: evidence for clustering and a power variance function.

Authors:  W S Kendal; F J Lagerwaard; O Agboola
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Solitary "necrotic nodule" of the liver: a probable pathogenesis.

Authors:  C L Berry
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

4.  The distribution of liver metastases from colonic cancer. A quantitative postmortem study.

Authors:  W Schulz; C Hagen; W Hort
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

5.  Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries.

Authors:  Patricia Tai; Edward Yu; Vincent Vinh-Hung; Gábor Cserni; Georges Vlastos
Journal:  BMC Cancer       Date:  2004-09-02       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.